The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Realistically, there’s a good chance your patients are using them to get GLP-1 agonists. And sometimes ... care process is the best course of action. We shouldn’t let a patient start with ...

Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

The research found that participants who used the class of drugs which includes Wegovy and Ozempic had a lower risk of 42 ...

Sitagliptin selectively inhibits the action of DPP-4 ... decline in ß-cell secretion. [1] In the presence of elevated glucose concentrations, GLP-1 and GIP increase insulin release and GLP ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Thank you for standing by for the Cigna Group's fourth quarter 2024 results review. At this time, all callers are in a listen ...

With one in eight Americans having taken a GLP-1 already — including 43% of those ... they may be able to spark more action toward getting started with — and staying on — new drugs and ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.